HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.

Abstract
Tumor necrosis factors (TNF) alpha and beta are structurally related cytokines that mediate a wide range of immunological, inflammatory, and cytotoxic effects. During bacterial infection of the bloodstream (sepsis), TNF-alpha induction by bacterial endotoxin is thought to be a major factor contributing to the cardiovascular collapse and critical organ failure that can develop. Despite antibiotic therapy, these consequences of sepsis continue to have a high mortality rate in humans. Here we describe a potent TNF antagonist, a TNF receptor (TNFR) immunoadhesin, constructed by gene fusion of the extracellular portion of human type 1 TNFR with the constant domains of human IgG heavy chain (TNFR-IgG). When expressed in transfected human cells, TNFR-IgG is secreted as a disulfide-bonded homodimer. Purified TNFR-IgG binds to both TNF-alpha and TNF-beta and exhibits 6- to 8-fold higher affinity for TNF-alpha than cell surface or soluble TNF receptors. In vitro, TNFR-IgG blocks completely the cytolytic effect of TNF-alpha or TNF-beta on actinomycin D-treated cells and is markedly more efficient than soluble TNFR (24-fold) or monoclonal anti-TNF-alpha antibodies (4-fold) in inhibiting TNF-alpha. In vitro, TNFR-IgG prevents endotoxin-induced lethality in mice when given 0.5 hr prior to endotoxin and provides significant protection when given up to 1 hr after endotoxin challenge. These results confirm the importance of TNF-alpha in the pathogenesis of septic shock and suggest a clinical potential for TNFR-IgG as a preventive and therapeutic treatment in sepsis.
AuthorsA Ashkenazi, S A Marsters, D J Capon, S M Chamow, I S Figari, D Pennica, D V Goeddel, M A Palladino, D H Smith
JournalProceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A) Vol. 88 Issue 23 Pg. 10535-9 (Dec 01 1991) ISSN: 0027-8424 [Print] United States
PMID1660140 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Immunoglobulin G
  • Immunoglobulin Heavy Chains
  • Lymphotoxin-alpha
  • Receptors, Cell Surface
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Dactinomycin
Topics
  • Animals
  • Antibodies, Monoclonal
  • Cell Survival (drug effects)
  • Chimera
  • Chromosome Deletion
  • Cloning, Molecular
  • Dactinomycin (pharmacology)
  • Female
  • Humans
  • Immunoglobulin G (genetics, immunology, isolation & purification)
  • Immunoglobulin Heavy Chains (genetics, immunology, isolation & purification)
  • Kinetics
  • L Cells
  • Lymphotoxin-alpha (immunology, metabolism, pharmacology)
  • Mice
  • Mice, Inbred BALB C
  • Mutagenesis, Site-Directed
  • Receptors, Cell Surface (genetics, immunology, isolation & purification)
  • Receptors, Tumor Necrosis Factor
  • Restriction Mapping
  • Salmonella Infections, Animal (immunology, prevention & control)
  • Shock, Septic (immunology, prevention & control)
  • Transfection
  • Tumor Necrosis Factor-alpha (immunology, metabolism, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: